AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
πΏπΌ
DOLUTEGRAVIR SODIUM in Zimbabwe
6 products registered with MCAZ β 6 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| DOLUTEGRAVIR SODIUM TABLET, COATED; ORAL | 2019/7.13/5923 | LAURUS LABS LIMITED | active | 14 Mar 2029 |
| MYLTEGA DT TABLET, COATED; ORAL | 2021/7.13/6164 | MYLAN LABORATORIES LIMITED [OTL] | active | 5 Dec 2028 |
| INSTGRA TABLET, COATED; ORAL | 2019/7.13/5770 | EMCURE PHARMACEUTICALS LTD | active | 13 Nov 2028 |
| DOLUTEGRAVIR SODIUM TABLET, COATED; ORAL | 2022/7.13/6359 | MACLEODS PHARMACEUTICALS LIMITED | active | 1 Nov 2028 |
| TIVICAY TABLET; ORAL | 2021/7.13/6129 | GLAXOSMITHKLINE S.A (PTY) LTD | active | 31 Dec 2027 |
| DOLUTEGRAVIR SODIUM TABLET, COATED; ORAL | 2024/7.13/6567 | STRIDES PHARMA SCIENCE LIMITED | active | 31 Dec 2027 |
DOLUTEGRAVIR SODIUM β MCAZ Registration Details
MCAZ (Zimbabwe) has 6 registered products containing DOLUTEGRAVIR SODIUM, of which 6 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.
Track DOLUTEGRAVIR SODIUM registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.